Sun, Dec 28, 2014, 7:08 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Cesca Therapeutics Inc. Message Board

  • hwmccusker hwmccusker Feb 13, 2013 8:06 AM Flag

    Earnings breakdown

    Q2 demonstrated improvement in gross margins and reduce operating expenses and the net loss by more than 50% versus Q2/12. Revenues increased nearly $700 K versus Q1/13. Together with the $500 K, KOOL received at the end of Q2 divestitures have generated … a total of $3.5 M in cash with $2.5 M received in the last 6 months. Restructuring and streamlining initiatives have reduced operating and overhead expenses by more than $2 M annually. Their cash position is good … compared to the past … so expect KOOL to pick up the price appreciation to above the NASDAQ limit of $1.00. On 11/15/12, KOOL received a notice from the NASDAQ notifying them that for 30 consecutive business days and have been provided with 180 calendar days (until 5/14/13) to regain compliance. The key will be breaking beyond the 50 day moving average of $0.93 and the comparable 200 day of $0.93. Momentum has been slow due to moderate volume which has been well below the 10 day numbers. KOOL had 1 day of compliance since 1/2/13. Ranking – BUY and a target pricing of $1.10 to $1.20 in the next 6 months.
    KOOL closed at $0.98, down $0.01 or -0.61%.

    Sentiment: Buy

1.08-0.05(-4.42%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Virgin America Inc.
NASDAQFri, Dec 26, 2014 4:00 PM EST
Ocwen Financial Corp.
NYSEFri, Dec 26, 2014 4:03 PM EST